Clinical Trials Directory

Trials / Completed

CompletedNCT00210197

Hypercoagulability After Breast Cancer Surgery

Plasma Coagulation Parameters and Hypercoagulability After Breast Cancer Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
Institut Bergonié · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The risk of deep venous thrombosis after radical breast surgery is known. The objective of this study is to explore hypercoagulability after radical breast cancer surgery by studying several factors for haemostasis before, during and after surgery. Ultrasound Doppler examination is realised between 24 and 72 hours post-operatively. Hypercoagulability is defined by a significant increasing level of thrombin-antithrombin, D-dimer and the endogen thrombin potential.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood collection (pre and postoperative): plasma coagulation parameters

Timeline

Start date
2005-01-01
Completion
2006-01-01
First posted
2005-09-21
Last updated
2013-07-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00210197. Inclusion in this directory is not an endorsement.